vs
Quipt Home Medical Corp.（QIPT）与Sotera Health Co（SHC）财务数据对比。点击上方公司名可切换其他公司
Sotera Health Co的季度营收约是Quipt Home Medical Corp.的6.2倍（$303.4M vs $49.0M）。Sotera Health Co净利率更高（11.5% vs -2.1%，领先13.6%）。Quipt Home Medical Corp.同比增速更快（32.3% vs 4.6%）。Sotera Health Co自由现金流更多（$52.4M vs $6.9M）
Quipt Home Medical Corp是一家总部位于美国的家用医疗设备服务商，主营呼吸护理、睡眠治疗用品及慢性病管理相关医疗产品，面向慢性病患者群体提供服务，合作方涵盖医疗机构与保险支付机构。
Sotera Health Co是全球领先的医疗安全解决方案提供商，面向医疗器械厂商、制药企业、食品及消费品公司提供灭菌服务、实验室分析检测与合规咨询支持，帮助客户满足监管要求，保障上市产品的使用安全。
QIPT vs SHC — 直观对比
营收规模更大
SHC
是对方的6.2倍
$49.0M
营收增速更快
QIPT
高出27.7%
4.6%
净利率更高
SHC
高出13.6%
-2.1%
自由现金流更多
SHC
多$45.5M
$6.9M
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $49.0M | $303.4M |
| 净利润 | $-1.1M | $34.8M |
| 毛利率 | 53.5% | 54.7% |
| 营业利润率 | 2.1% | 23.2% |
| 净利率 | -2.1% | 11.5% |
| 营收同比 | 32.3% | 4.6% |
| 净利润同比 | 2.9% | 182.8% |
| 每股收益（稀释后） | $-0.02 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收QIPTSHC
| Q4 25 | $49.0M | $303.4M | ||
| Q3 25 | $39.8M | $311.3M | ||
| Q2 25 | $35.1M | $294.3M | ||
| Q1 25 | $33.3M | $254.5M | ||
| Q4 24 | $37.1M | $290.2M | ||
| Q3 24 | — | $285.5M | ||
| Q2 24 | — | $276.6M | ||
| Q1 24 | — | $248.2M |
净利润QIPTSHC
| Q4 25 | $-1.1M | $34.8M | ||
| Q3 25 | $-3.5M | $48.4M | ||
| Q2 25 | $-3.0M | $8.0M | ||
| Q1 25 | $-3.0M | $-13.3M | ||
| Q4 24 | $-1.1M | $12.3M | ||
| Q3 24 | — | $17.0M | ||
| Q2 24 | — | $8.8M | ||
| Q1 24 | — | $6.3M |
毛利率QIPTSHC
| Q4 25 | 53.5% | 54.7% | ||
| Q3 25 | 48.7% | 57.0% | ||
| Q2 25 | 57.6% | 56.6% | ||
| Q1 25 | 54.6% | 53.2% | ||
| Q4 24 | 52.1% | 56.6% | ||
| Q3 24 | — | 55.4% | ||
| Q2 24 | — | 55.2% | ||
| Q1 24 | — | 51.2% |
营业利润率QIPTSHC
| Q4 25 | 2.1% | 23.2% | ||
| Q3 25 | -3.6% | 23.4% | ||
| Q2 25 | -5.2% | 6.4% | ||
| Q1 25 | -3.0% | -5.8% | ||
| Q4 24 | 1.2% | 30.0% | ||
| Q3 24 | — | 28.2% | ||
| Q2 24 | — | 27.8% | ||
| Q1 24 | — | 21.4% |
净利率QIPTSHC
| Q4 25 | -2.1% | 11.5% | ||
| Q3 25 | -8.9% | 15.5% | ||
| Q2 25 | -8.6% | 2.7% | ||
| Q1 25 | -9.1% | -5.2% | ||
| Q4 24 | -2.9% | 4.2% | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.5% |
每股收益（稀释后）QIPTSHC
| Q4 25 | $-0.02 | $0.12 | ||
| Q3 25 | $-0.07 | $0.17 | ||
| Q2 25 | $-0.07 | $0.03 | ||
| Q1 25 | $-0.07 | $-0.05 | ||
| Q4 24 | $-0.03 | $0.05 | ||
| Q3 24 | — | $0.06 | ||
| Q2 24 | — | $0.03 | ||
| Q1 24 | — | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.5M | $344.6M |
| 总债务越低越好 | $84.0M | $2.1B |
| 股东权益账面价值 | $113.0M | $606.0M |
| 总资产 | $280.7M | $3.3B |
| 负债/权益比越低杠杆越低 | 0.74× | 3.53× |
8季度趋势，按日历期对齐
现金及短期投资QIPTSHC
| Q4 25 | $10.5M | $344.6M | ||
| Q3 25 | $12.9M | $299.2M | ||
| Q2 25 | $11.3M | $332.4M | ||
| Q1 25 | $17.1M | $304.4M | ||
| Q4 24 | $15.5M | $277.2M | ||
| Q3 24 | — | $306.7M | ||
| Q2 24 | — | $246.1M | ||
| Q1 24 | — | $261.1M |
总债务QIPTSHC
| Q4 25 | $84.0M | $2.1B | ||
| Q3 25 | $87.6M | $2.1B | ||
| Q2 25 | $66.0M | $2.2B | ||
| Q1 25 | $71.5M | $2.2B | ||
| Q4 24 | $70.6M | $2.2B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $2.2B |
股东权益QIPTSHC
| Q4 25 | $113.0M | $606.0M | ||
| Q3 25 | $112.1M | $550.5M | ||
| Q2 25 | $102.5M | $511.3M | ||
| Q1 25 | $103.6M | $414.1M | ||
| Q4 24 | $106.3M | $404.9M | ||
| Q3 24 | — | $470.2M | ||
| Q2 24 | — | $422.8M | ||
| Q1 24 | — | $429.4M |
总资产QIPTSHC
| Q4 25 | $280.7M | $3.3B | ||
| Q3 25 | $283.3M | $3.2B | ||
| Q2 25 | $236.1M | $3.2B | ||
| Q1 25 | $244.6M | $3.1B | ||
| Q4 24 | $242.8M | $3.1B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.1B | ||
| Q1 24 | — | $3.1B |
负债/权益比QIPTSHC
| Q4 25 | 0.74× | 3.53× | ||
| Q3 25 | 0.78× | 3.89× | ||
| Q2 25 | 0.64× | 4.34× | ||
| Q1 25 | 0.69× | 5.36× | ||
| Q4 24 | 0.66× | 5.49× | ||
| Q3 24 | — | 4.73× | ||
| Q2 24 | — | 5.26× | ||
| Q1 24 | — | 5.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.9M | $103.1M |
| 自由现金流经营现金流 - 资本支出 | $6.9M | $52.4M |
| 自由现金流率自由现金流/营收 | 14.0% | 17.3% |
| 资本支出强度资本支出/营收 | 4.2% | 16.7% |
| 现金转化率经营现金流/净利润 | — | 2.96× |
| 过去12个月自由现金流最近4个季度 | $26.6M | $149.2M |
8季度趋势，按日历期对齐
经营现金流QIPTSHC
| Q4 25 | $8.9M | $103.1M | ||
| Q3 25 | $9.8M | $71.2M | ||
| Q2 25 | $9.7M | $57.4M | ||
| Q1 25 | $8.9M | $55.5M | ||
| Q4 24 | $9.3M | $55.7M | ||
| Q3 24 | — | $97.5M | ||
| Q2 24 | — | $61.3M | ||
| Q1 24 | — | $9.7M |
自由现金流QIPTSHC
| Q4 25 | $6.9M | $52.4M | ||
| Q3 25 | $8.0M | $35.0M | ||
| Q2 25 | $4.4M | $26.2M | ||
| Q1 25 | $7.3M | $35.6M | ||
| Q4 24 | $5.6M | $-10.2M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $19.4M | ||
| Q1 24 | — | $-25.2M |
自由现金流率QIPTSHC
| Q4 25 | 14.0% | 17.3% | ||
| Q3 25 | 20.0% | 11.2% | ||
| Q2 25 | 12.6% | 8.9% | ||
| Q1 25 | 22.0% | 14.0% | ||
| Q4 24 | 15.2% | -3.5% | ||
| Q3 24 | — | 21.4% | ||
| Q2 24 | — | 7.0% | ||
| Q1 24 | — | -10.2% |
资本支出强度QIPTSHC
| Q4 25 | 4.2% | 16.7% | ||
| Q3 25 | 4.6% | 11.6% | ||
| Q2 25 | 14.9% | 10.6% | ||
| Q1 25 | 4.8% | 7.8% | ||
| Q4 24 | 9.9% | 22.7% | ||
| Q3 24 | — | 12.7% | ||
| Q2 24 | — | 15.2% | ||
| Q1 24 | — | 14.1% |
现金转化率QIPTSHC
| Q4 25 | — | 2.96× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | — | 7.21× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.52× | ||
| Q3 24 | — | 5.73× | ||
| Q2 24 | — | 7.00× | ||
| Q1 24 | — | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
QIPT
暂无分部数据
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
